Details for 2012744254
Up to date per 02.04.2026
Actions
Details for 2012744254
Granted/Registered
European Patent
18.12.2013 A
07.11.2018 B1
11.02.2011
US
201161441893 P
C07F 7/02 20060101AFI20170106BHEP
Owner
ZS Pharma, Inc508 Wrangler Dr., Suite 100 Coppell, TX 75019-7609US
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
KEYSER, Donald, Jeffrey1216 Wyndham Hill Lane Southlake, Texas 76092US
GUILLEM, Alvaro, F.727 Lathrop Street Lantana, Texas 76226US
Information about Fees